Journal
MOLECULAR PHARMACEUTICS
Volume 8, Issue 6, Pages 2183-2192Publisher
AMER CHEMICAL SOC
DOI: 10.1021/mp100418u
Keywords
organic anion transporter; aristolochic acid nephropathy; kidney toxicity; Oat1 and 3 knockout mice
Funding
- National Basic Research Program (973 Program) [2006CB504701]
- National Key Technologies RD Program [2009ZX09301-001, 2008ZX09305-007, 2009ZX09501-033]
- Nagai Foundation Tokyo
Ask authors/readers for more resources
Ingestion of atistolochic acid (AA), especially its major constituent aristolochic acid I (AAI), results in severe kidney injury known as aristolochic acid nephropathy (AAN). Although hepatic cytochrome P450s metabolize AAI to reduce its kidney toxicity in mice, the mechanism by which AAI is uptaken by renal cells to induce renal toxicity is largely unknown. In this study, we found that organic anion transporters (OATs) 1 and 3, proteins known to transport drugs from the blood into the tubular epithelium, are responsible for the transportation of AM into renal tubular cells and the subsequent nephrotoincity. AAI uptake in HEK 293 cells stably transfected with human OAT1 or OAT3 was greatly increased compared to that in the control cells, and this uptake was dependent on the AAI concentration. Administration of probenecid, a well-known OAT inhibitor, to the mice reduced AAI renal accumulation and its urinary excretion and protected mice from AM-induced acute tubular necrosis. Further, AAI renal accumulation and severe kidney lesions induced by AAl in Oat1 and OAT3 gene knockout mice all were markedly suppressed compared to those in the wild-type mice. Together, our results suggest that OAT1 and OAT3 have a critical role in AAlrenal accumulation and toxicity. These transporters may serve as a potential therapeutic target against AAN.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available